Spiros Angelou Vlahopoulos, Ph.D., a researcher at the N.K. University of Athens 1st Pediatric Clinic. He earned a Diploma in Biology in 1993 at the University of Cologne Genetics Department and a PhD in Biology in 1999 at the University of Texas Medical Branch at Galveston. He conducted postdoctoral research at Baylor College of Medicine. His main areas of interest regard cellular signaling mechanisms elicited by homeostatic imbalance and developmental stimuli exemplified by anoikis, nuclear factor kappa B feedback networks, and interference between signals transduced by hormone receptors and inflammation-induced transactivators. He is currently studying gene targets for the modulation of immune system interactions with other systems and host tissues. He became a member of FASEB in 2004.
Garrett M. Dancik is a professor at the Department of Computer Science, Eastern Connecticut State University, Willimantic, CT, USA. He received a Ph.D. in bioinformatics and computational biology and an MS in statistics from Iowa State University in 2008. His research interests include bioinformatics computational biology and data science more broadly. His bioinformatics research focuses on the development and application of computational tools for analyzing large genomic datasets, with applications in personalized medicine; the identification of prognostic and predictive
biomarkers in cancer; and the development, validation, and calibration of
computational/mathematical models of biological systems. He has also developed educational tools for data science.
Theodoros Karantanos graduated from the School of Health Sciences at the University of Athens, Greece, and received a PhD in cancer biology. As a postdoctoral research fellow at MD Anderson Cancer
Center/University of Texas, he studied signal transduction in cancer and developed expertise in mouse modeling and targeted therapies. He is an instructor of medical oncology at Sidney Kimmel Cancer Center/Johns Hopkins University at the Division of Hematologic Malignancies. His current research focuses on the elucidation of growth-related pathways in MDS/sAML and the discovery of novel therapies to suppress them utilizing CRISPR-Cas9 technology, proteomics analysis, high-throughput drug screens, analysis of primary samples and xenograft models.
Istvan Boldogh earned his MS in biochemistry from the Central University of Debrecen, Hungary, in 1970. He obtained his doctor of medicine and biology from the School of Medicine, Debrecen, in 1974. He pursued his candidacy for doctor of sciences at the Hungarian Academy of Sciences, Budapest, completing it in 1986. In 2010, he was awarded an honorary doctor honoris causa from Semmelweis Medical School, Budapest, Hungary. Currently, he holds the position of professor at the Department of Microbiology and Immunology, School of Medicine, University of Texas, USA. His primary research interests revolve around the epigenetic regulations in innate inflammation. He has authored over 350 publications, with more than 23,220 citations, an h-index of 89, and an i10-index of 251.
